You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Sweden

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Sweden with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Sweden, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Sweden for free:

The Consumer Health in Sweden market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Sweden?
  • What are the major brands in Sweden?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Resilience to wider economic forces

Despite the weak economic climate, Swedish consumer health sales proved to be relatively immune to wider economic forces. Consumer health posted strong retail value growth once again in 2010, albeit slower than the CAGR recorded for the review period as a whole. Most mature consumer health categories proved to be resilient and posted healthy growth rates as consumers still needed to attend to their minor ailments. Growth in 2010 was also supplemented and supported by a number of other factors such as the self-medication trend, liberalisation of pharmacy sales, the continued ageing of the Swedish population and increased category segmentation.

Liberalisation boosts sales growth

The de-regulation of pharmacy sales occurred in November 2009, leading to the entry of numerous new pharmacy chains. As part of this process the sale of certain OTC medicines was liberalised with distribution via mass market channels such as supermarkets and hypermarkets now possible. This change led to a strong boost in sales prompted by the greater availability and distribution of consumer health products. However, despite the de-regulation of pharmacy sales, subsequent entry of new players in pharmacy retailing sales and product availability in mass market channels, increased or significant price competition had yet to occur in Swedish consumer health at the end of the review period. The lack of price competition in the context of greater product distribution consequently encouraged the recording of strong current retail value growth rates for 2010.

Increasing concentrated environment

Consumer health’s sales were increasingly characterised by consolidation; numerous categories are dominated by a handful of players. Indeed major players are not just confined to one area of consumer health but have an overall presence across the spectrum of total consumer health sales. 2010 was also a year that witnessed merger and acquisition activity. The domestic player, Meda AB, firmly stated strategic goals to establish itself as a leading player. This will be achieved through a combination of organic growth and acquisition, as the company’s acquisition of BioPhausia OTC medicine product portfolio in September 2010 indicates.

Distribution increasingly diverse

Even though chemists/pharmacies remains as the largest generator of sales, the expansion of internet retailing, the inclusion of grocery retailers, and the liberalisation of the pharmacy channel are changing the retailing arena of Swedish consumer health. The distribution of consumer health products in 2010 was much more diverse and varied than review period recordings. De-regulation significantly boosted the share held by grocery retailers; namely, supermarkets, hypermarkets and forecourt retailers. This in turn led to a decrease in the total share held by chemists/pharmacies.

Positive outlook

The outlook for consumer health in Sweden is positive. Growth will continue to be encouraged by review period factors; namely, the self-medication trend, liberalisation of pharmacy sales, the continued ageing of the Swedish population and increased category segmentation. Trade sources are of the opinion, however, that increased price competition will characterise future sales development. This will be a bi-product of the expected growth of private label. For instance, the pharmacy chain Apoteket launched private label in analgesics in late 2010 and in the process, indicated its intention to launch more consumer health private label in the coming years. With other retailers likely to follow the lead of Apoteket, increased price competition is unavoidable.

Table of Contents

Table of Contents

Consumer Health in Sweden - Industry Overview

EXECUTIVE SUMMARY

Resilience to wider economic forces

Liberalisation boosts sales growth

Increasing concentrated environment

Distribution increasingly diverse

Positive outlook

KEY TRENDS AND DEVELOPMENTS

The population continues to age

Consumer healthcare proves resilient to wider economic forces

Health and wellness – a driver of sales

Swedish consumers are more willing to self-medicate

Liberalisation does not lead to increased price competition

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Advertising

Standardised Packaging Requirements

Vitamins and Dietary Supplements Registration and Classification

Advertising

Self-medication/self-care and Preventative Medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 2 Research Sources

Consumer Health in Sweden - Company Profiles

Abigo Medical AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Abigo Medical AB: Competitive Position 2010

Antula Healthcare AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Antula Healthcare AB: Competitive Position 2010

Friggs AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 11 Friggs AB: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 12 Friggs AB: Competitive Position 2010

Meda AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 15 Meda AB: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 16 Meda AB: Competitive Position 2010

Niconovum AB in Consumer Health (Sweden)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 19 Niconovum AB: Competitive Position 2009

Adult Mouth Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • There still exists a fine line in adult mouth care, where it is difficult for many consumers to differentiate oral health care products tracked in beauty and personal care from medicated adult mouth care products tracked in consumer health. Low-strength mouthwashes claiming to prevent gingivitis can be confused with the actual treatments for gingivitis.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ipex Medical AB was the leading category player in 2010 with a value share of 37%, although the company lost five percentage points of share to Antual Healthcare AB in 2010. Ipex Medical is the national brand owner of the popular Dentan, Dentan Mint and Hexident brands. Dentan Mint is the leading brand in current value sales terms with a 2010 value share of 22%. Dentan Mint outperformed the unflavoured Dentan brand in the latter years of the review period indicating Swedish consumer preferences for flavoured OTC mouthwash products. This suggests consumers perceive or prefer OTC mouthwash products to have a dual functionality, such as mouth care and mouth freshness.

PROSPECTS

  • Competition from oral health care is the main threat to forecasts. Oral health care products are increasingly becoming more advanced in their product formulations leading to a blurring of the boundaries between oral health care and adult mouth care. This will continue to confuse consumers in the forecast period with a negative impact on potential growth rates for adult mouth care sales.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Sweden - Category Analysis

HEADLINES

TRENDS

  • Liberalisation of consumer health was the single most important factor shaping analgesics’ sales in 2010. According to Läkemedelsverket, approximately 6,500 retail outlets are now permitted to sell certain analgesics in the country. A secondary and more general factor driving growth is the self-medication trend. Swedish consumers are all the more likely to self-medicate and diagnose minor ailments and medical complaints.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sales were concentrated with GlaxoSmithKline Sweden AB and McNeil Sweden AB controlling a combined value share of 71%. Both companies hold several of the most popular brands. GlaxoSmithKline acquired two brands from AstraZeneca AB in 2009; top selling brands Alvedon and Reliv, both acetaminophen, and this contributed to an increase in value share from 9% in 2008 to 36% in 2009. GlaxoSmithKline’s third brand is Panodil. The acquisition of Alvedon and Reliv gave the company a 100% share in acetaminophen for 2009. Despite the entry of Apoteket AB into acetaminophen in 2010 with the launch of Apofri Paracetamol, GlaxoSmithKline continued to dominate the segment with a 2010 current retail value share of 99%.

PROSPECTS

  • Pain deriving from an ageing body will boost future sales. In addition to this, liberalisation of consumer health and the self-medication trend will continue to have positive impacts on growth rates throughout the forecast period.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Sweden - Category Analysis

HEADLINES

TRENDS

  • Increased product availability and distribution in mass market channels such as supermarkets and hypermarkets was a key driver of category growth in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Cederroth International AB was the leading category player with a 2010 value share of 38%. The company is the national brand owner of the leading Valerina brand. Unlike the majority of other calming and sleeping products brands present, Valerina enjoys mass market distribution as it is stocked in grocery retailers, pharmacies and other healthcare specialist stores. The wide and varied distribution network supports Valerina’s leadership position and consequently Cederroth’s position as the leading company.

PROSPECTS

  • Busy lives in urban environments are causing stress and lack of sleep; however, calming and sleeping will continue to represent a very small category in consumer health. Consumption of alcohol and holistic practices will remain important competitors of calming and sleeping products.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Sweden - Category Analysis

HEADLINES

TRENDS

  • The de-regulation of pharmacy sales in November 2009 had a positive impact on 2010 sales developments. De-regulation led to an increase in product availability and distribution as grocery retailers are now permitted to carry and sell certain cough, cold and allergy remedies previously restricted to the chemists/pharmacies. Nasal sprays in particular benefitted from de-regulation, recording retail value growth of 11% for 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Sverige AB was the leading category player with a 2010 retail value share of 18%. Novartis Sverige AB is the national brand owner of a number of popular cough, cold, allergy remedies brands such as Otrivin and Strespils. Consumer recognition and loyalty to these brands supports and strengthens the company’s value share.

PROSPECTS

  • De-regulation of consumer health will continue to have a positive influence over forecasts, especially nasal sprays.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2008-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2008-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Sweden - Category Analysis

HEADLINES

TRENDS

  • The ageing population is a key driver of category sales. Ageing can lead to difficulties in digesting food. Acidity, heartburn and constipation continue to offer good opportunities for growth of digestive remedies in Sweden. According to research undertaken by Novartis, approximately 36% of the Swedish population suffered from indigestion complaints in a given six month period. This statistic reveals the strong demand and growth potential for Swedish digestive remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • In national brand owner terms, McNeil Sweden AB was the leading category player with a retail value share of 19% in 2010. McNeil Sweden is the NBO of several popular and leading digestive remedies brands in Sweden, including diarrhoeal remedy Imodium, H2 blocker Pepcid Duo and laxative Microlax.

PROSPECTS

  • De-regulation will continue to drive sales growth over the forecast period. Similar to the review period, the continued ageing of the population will increase the absolute demand for digestive remedies.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • The growing popularity of self-medication is a key driver of category growth. Problems with ear wax are regarded as suitable for self-medication, and there are few who visit a doctor for such a problem. For minor illnesses and problems, self-medication is also encouraged by the health authorities in order to limit the pressure on and cost of the overall health care system.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ear care sales were led by Orion Pharma AB’s brand Revaxör which held a retail value share of 56% in 2010. Revaxör is the most widely distribution ear care brand available. The low absolute value of ear care sales in Sweden and subsequent lack of competing brands present are factors supporting Revaxör’s leading position. Cerusol from Ipex Medical AB is the only other ear care brand that is widely distributed and that has the same level of market reach as the Revaxör brand.

PROSPECTS

  • Ear wax and ear care-related problems are particularly common to elderly consumers. The continued ageing of the Swedish population and continued trend towards self-medication offer possible growth opportunities for ear care sales.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in Sweden - Category Analysis

HEADLINES

TRENDS

  • Casual attitudes to sexual intercourse are supporting the demand for emergency contraception in Sweden. These attitudes are perhaps linked to consumers’ lack of concern for the transmission of sexual infections. In addition to this, a general factor supporting category demand is the growing trend towards self-medication.

COMPETITIVE LANDSCAPE

  • Nycomed AB was the category leader with a 2010 current value share of 70%. The company is the national brand owner of the leading emergency contraception brand NorLevo. NorLevo was the first emergency contraception brand to be available in Sweden and therefore gained from first-mover advantage. Through first-mover advantage, the brand has built up a distribution network to support its current position.

PROSPECTS

  • Casual attitudes to sexual intercourse will ensure continued demand for emergency contraception in the forecast period. Consumer willingness to self-medicate will also support this demand. However increased awareness of the dangers associated with unprotected sexual intercourse will negatively influence sales forecasts in relation to review period results. This result in positive forecast growth rates but the absolute magnitude of these growth rates will be lower than those recorded in the review period.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • Eye care is an emerging growth category due to the high incidence of eye problems and macular degeneration among the elderly.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Sverige AB is the leading player with a 2010 retail value share of 21%. This is linked to the company’s strong position in standard eye care. Its Viscotears accounted for 24% share of standard eye care sales.

PROSPECTS

  • The growing self-medication trend, increased product distribution and the continued ageing of the Swedish population will drive forecast growth.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Sweden - Category Analysis

HEADLINES

TRENDS

  • Growth is driven by consumers seeking a more “natural” approach to healing and prevention.

COMPETITIVE LANDSCAPE

  • Medicated confectionary market players dominate sales of herbal/traditional products in 2010, due to the dominance of medicated confectionery overall. As all medicated confectionary sales are by definition herbal/ traditional, medicated confectionery was largely responsible for herbal cough, cold and allergy (hay fever) remedies accounting for 51% of overall value sales in herbal/traditional products in 2010. The leading brands in 2010 were Vicks from Procter & Gamble Sweden and Fisherman’s Friend from Adaco AB. Green Medicine AB was ranked second with one of the most popular cough and cold remedy brands, Kan Jang.

PROSPECTS

  • Consumer interest in alternative therapies and using non-OTC products will remain at a high level over the forecast period. Despite negative attitudes from health authorities, consumers will continue to retain an interest in herbal/traditional products as an alternative or complement to Rx and OTC products.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • Skin care is an important competitor to consumer health category medicated skin care. A fine line continues to exist in acne treatments, where it is difficult for many consumers to differentiate cleansers and toners to help with acne from the medicated acne treatments tracked in consumer health. This is having a negative impact on retail value growth rates.

SWITCHES

COMPETITIVE LANDSCAPE

  • Antula Healthcare AB was the leading category player in 2010 with a value share of 12%. The company controls a number of popular and strong medicated skin care brands in Sweden such as the cold sore treatment Anti and the haemorrhoid treatment AC3 Comfort. Both Anti and AC3 Comfort are leading brands in high growth segments of medicated skin care. This is facilitating the growth of Antula’s total medicated skin care sales and supporting its leading position.

PROSPECTS

  • Increased competition from non-consumer health products such as cosmetics will continue to present a challenge to the growth of medicated skin care as a whole over the forecast period.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

OTC Triptans in Sweden - Category Analysis

HEADLINES

TRENDS

  • The growing self-medication trend is a key driver of category sales. OTC triptans are most likely to be purchased by consumers who believe they are suffering from a migraine but who have not been diagnosed by a medical professional as such.

COMPETITIVE LANDSCAPE

  • AstraZeneca AB was the leading category player with a 2010 current value share of 54%. The company’s Zomig Nasal was the first OTC triptan brand to gain OTC status in Sweden. AstraZeneca capitalised on its first-mover advantage offered by extensively promoting its brand to build a dominant category position. This was achieved through the building of strong distribution relationships and heavy advertising campaigns.

PROSPECTS

  • The self-medication trend will remain a key driver of forecast growth. Swedish consumers are all the more likely to self-diagnose perceived minor illnesses to avoid the inconvenience and cost of seeking professional medical advice.

CATEGORY DATA

  • Table 81 Sales of OTC Triptans: Value 2008-2010
  • Table 82 Sales of OTC Triptans: % Value Growth 2008-2010
  • Table 83 OTC Triptans Company Shares by Value 2006-2010
  • Table 84 OTC Triptans Brand Shares by Value 2007-2010
  • Table 85 Forecast Sales of OTC Triptans: Value 2010-2015
  • Table 86 Forecast Sales of OTC Triptans: % Value Growth 2010-2015

Sports Nutrition in Sweden - Category Analysis

HEADLINES

TRENDS

  • A rise in the adoption of sports and fitness routines contributed to gains in sales for sports nutrition. However, safety and quality concerns regarding the ingredients used in some sports nutrition products are now prompting regulatory revision in this category through warnings and product recalls.

COMPETITIVE LANDSCAPE

  • Sports nutrition remained fragmented with a high number of players. However, sales witnessed a degree of consolidation over the review period with the bulk of sales increasingly concentrated between a relatively small number of players.

PROSPECTS

  • Sport nutrition in Sweden are expected to reach constant value sales of SEK405 million in 2015, which represents an increase of 25% on 2010 estimates.

CATEGORY DATA

  • Summary 20 Sports Nutrition, Category Rankings 2010
  • Table 87 Sales of Sports Nutrition: Value 2005-2010
  • Table 88 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 89 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 90 Sports Nutrition Company Shares 2006-2010
  • Table 91 Sports Nutrition Brand Shares 2007-2010
  • Table 92 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 93 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Sweden - Category Analysis

HEADLINES

TRENDS

  • Innovation is a key driver of Swedish vitamins and dietary supplements. Innovation is particularly evident in the format/packaging and marketing of products. Examples of innovations within format/packaging are sticks, sprays and so-called day-packs. A day-pack contains the daily vitamin and dietary supplement needs of consumers. Friggs Multiman Optimal and Friggs Multikvinna Opitmal are brand examples of day-packs. These two products are also examples of another important trend shaping category sales; namely the segmentation of products for men, women, the elderly and children.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Friggs AB is the leading category player with a 2010 value share of 15% in 2010. Its leadership position is linked to the widely recognised Friggs brand. Friggs is present in most segments in vitamins and dietary supplements, and has a particularly strong position in grocery retailers. Friggs’ products have competitive prices compared with most competitors.

PROSPECTS

  • Strong trends toward natural healing and prevention over the forecast period will benefit vitamins and dietary supplements. Rising awareness of healthy lifestyles will drive sales.

CATEGORY DATA

  • Summary 21 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 94 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 95 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 96 Dietary Supplements by Positioning 2005-2010
  • Table 97 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 98 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 99 Vitamins Brand Shares by Value 2007-2010
  • Table 100 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 102 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Sweden - Category Analysis

HEADLINES

TRENDS

  • Preoccupation with weight and obesity was the key driver of category sales. Weight management is, however, facing increased competition from health and wellness trends for exercise and healthy diets based on fruit, vegetables, grains and protein. Strong trends favouring exercise and healthy meals are encouraging Swedish consumers to gradually move away from slimming products.

COMPETITIVE LANDSCAPE

  • Four companies dominated slimming products in 2010, with Axellus AB and its popular Nutrilett brand in the lead with a 24% value share. Nutrilett is distributed in both grocery and non-grocery channels. Friggs AB was ranked second with a 14% share with the two brands Naturdiet and DR Kousa. Cederroth International AB saw rapid growth with the Allévo brand, launched in 2007, and reached a 14% share in 2010.

PROSPECTS

  • A preoccupation with weight and obesity concerns will remain as the key driver of category sales.

CATEGORY DATA

  • Table 103 Sales of Weight Management: Value 2005-2010
  • Table 104 Sales of Weight Management: % Value Growth 2005-2010
  • Table 105 Weight Management Company Shares 2006-2010
  • Table 106 Weight Management Brand Shares 2007-2010
  • Table 107 Forecast Sales of Weight Management: Value 2010-2015
  • Table 108 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Sweden - Category Analysis

HEADLINES

TRENDS

  • Swedish wound care sales are mature. As such, segmentation is a key driver of retail value growth for the category. This is highlighted by new product developments such as Salvekvick Foot Care by Cederroth International AB in 2010.

COMPETITIVE LANDSCAPE

  • Cederroth International AB was the leading category player with a 2010 current value share of 37%. Cederroth is the national brand owner of the popular and widely recognised Salvekvick brand, which enjoys mass market distribution.

PROSPECTS

  • Growth is expected to continue to be driven by product improvements and the increasing penetration of designed plasters.

CATEGORY DATA

  • Table 109 Sales of Wound Care by Category: Value 2005-2010
  • Table 110 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 111 Wound Care Company Shares by Value 2006-2010
  • Table 112 Wound Care Brand Shares by Value 2007-2010
  • Table 113 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 114 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Guarana
            • Isoflavones
            • Rosehip
            • Roseroot
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Yeast
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Future Demographic

Country Report